Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-10-23 Sale |
2020-10-23 5:32 pm |
IMMUNOMEDICS INC | IMMU | Duncan Barbara Gayle Director |
49,244 | $0 | $0 | 0 (Direct) |
View |
| 2020-09-15 Sale |
2020-09-16 6:43 pm |
Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director |
10,000 | $10 | $100,000 | 34,271 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-12 Option Award |
2024-12-16 4:15 pm |
N/A 2034-12-11 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-21 6:12 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
70,800 | $0 | 70,800 (Direct) |
View |
| 2024-06-16 Exercise |
2024-06-18 5:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
33,150 | $0 | 33,150 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:54 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Duncan Barbara Gayle Director |
15,305 | $0 | 24,558 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:54 pm |
N/A 2034-02-21 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:05 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
79,900 | $0 | 79,900 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-14 5:06 pm |
N/A 2033-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | Duncan Barbara Gayle Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-09 6:16 pm |
2024-05-05 2033-05-05 |
HALOZYME THERAPEUTICS INC. | HALO | Duncan Barbara Gayle Director |
19,436 | $0 | 20,624 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:47 pm |
N/A 2033-02-22 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:06 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Duncan Barbara Gayle Director |
1,188 | $0 | 1,188 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 5:01 pm |
2023-07-01 2032-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Duncan Barbara Gayle Director |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:02 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-22 7:07 pm |
N/A 2032-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | Duncan Barbara Gayle Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 7:49 pm |
N/A 2032-06-16 |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
61,264 | $0 | 61,264 (Direct) |
View |
| 2022-04-08 Option Award |
2022-04-12 4:55 pm |
N/A 2032-04-07 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
21,347 | $0 | 21,347 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 8:48 pm |
N/A 2032-02-02 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:00 pm |
2022-07-01 2031-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Duncan Barbara Gayle Director |
379,788 | $0 | 379,788 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:45 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-21 5:35 pm |
N/A 2031-06-17 |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
34,025 | $0 | 34,025 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-11 8:31 pm |
N/A 2031-06-10 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:14 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | Duncan Barbara Gayle Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-18 8:57 pm |
N/A 2031-05-16 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
1,750 | $0 | 1,750 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-03 4:56 pm |
N/A 2030-10-29 |
Fusion Pharmaceuticals Inc. | FUSN | Duncan Barbara Gayle Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 5:49 pm |
N/A 2030-10-28 |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-16 6:43 pm |
N/A 2026-05-09 |
Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director |
10,000 | $0 | 34,271 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-16 6:43 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director |
10,000 | $4.21 | 34,271 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-15 4:30 pm |
N/A N/A |
IMMUNOMEDICS INC | IMMU | Duncan Barbara Gayle Director |
2,500 | $16.96 | 52,962 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-15 4:30 pm |
2020-03-05 2026-03-05 |
IMMUNOMEDICS INC | IMMU | Duncan Barbara Gayle Director |
2,500 | $0 | 52,962 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-20 4:15 pm |
N/A N/A |
IMMUNOMEDICS INC | IMMU | Duncan Barbara Gayle Director |
20,000 | $16.96 | 50,462 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-20 4:15 pm |
2020-03-05 2026-03-05 |
IMMUNOMEDICS INC | IMMU | Duncan Barbara Gayle Director |
20,000 | $0 | 50,462 (Direct) |
View |
| 2020-08-12 Exercise |
2020-08-14 4:33 pm |
N/A N/A |
IMMUNOMEDICS INC | IMMU | Duncan Barbara Gayle Director |
17,077 | $12.93 | 30,462 (Direct) |
View |
| 2020-08-12 Exercise |
2020-08-14 4:33 pm |
2020-06-07 2026-06-07 |
IMMUNOMEDICS INC | IMMU | Duncan Barbara Gayle Director |
17,077 | $0 | 30,462 (Direct) |
View |
| 2020-06-26 Option Award(A) |
2020-07-02 7:32 pm |
N/A 2030-06-26 |
Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2020-07-01 Option Award |
2020-07-01 5:06 pm |
2021-07-01 2030-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Duncan Barbara Gayle Director |
144,000 | $0 | 144,000 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-29 7:30 pm |
N/A 2030-06-26 |
Jounce Therapeutics Inc. | JNCE | Duncan Barbara Gayle Director |
13,550 | $0 | 13,550 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 5:19 pm |
2021-06-18 2030-06-18 |
IMMUNOMEDICS INC | IMMU | Duncan Barbara Gayle Director |
10,258 | $0 | 19,925 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-08 5:37 pm |
N/A 2030-06-04 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
13,250 | $0 | 13,250 (Direct) |
View |